國家衛生研究院 NHRI:Item 3990099045/10835

NHRI > National Institute of Cancer Research > Li-Tzong Chen > Conference Papers/Meeting Abstract > Item 3990099045/10835

Please use this identifier to cite or link to this item: http://ir.nhri.org.tw/handle/3990099045/10835

Title:	Inhibition of the ubiquitin-conjugating enzyme E2B restores the BCNU sensitivity of cancer cells by regulating MGMT ubiquitination
Authors:	Hsu, SH;Chen, SH;Chen, LT;Chang, JY
Contributors:	National Institute of Cancer Research
Abstract:	Background:O6-Methylguanine-DNA methyltransferase (MGMT) is a DNA repair enzyme that removes the mutagenic O6-alkyl groups from guanines. 1, 3-Bis (2-chloroethyl)-1-nitrosourea (BCNU), a DNA damage reagent, is known to induce cell death of tumors and the ubiquitin dependent proteolysis of MGMT. The present study aims to enhance BCNU cytotoxicity toward cancer cells by modulating MGMT dynamics. Methods: Human nasopharygeal carcinoma cells, including HONE-1 and TW01, and human colon carcinoma HT-29 cells were used for the BCNU treatments, siRNA knockdown, immunoprecipitation and western blot experiments. The BCNU cytotoxicity was determined using methylene blue assay. Proteins involved in MGMT ubiquitination were confirmed with immunofloresence staining and in vitro protein ubiquitination assays. Results: We previously identified ubiquitin-conjugating enzyme E2B (UBE2B), a DNA repair enzyme with ubiquitin-conjugating abilities, as a critical regulator of the cell cycle in oral cancer cells. A novel role of UBE2B was further revealed in regulating MGMT dynamics in nasopharygeal carcinoma cells and colon carcinoma cells. Increased colocalization of UBE2B with MGMT was found in BCNU treated cancer cells. Depletion of MGMT or UBE2B in cancer cells resulted in decreased IC50 for BCNU. Lower MGMT expression levels were observed in UBE2B deficient cells. Overexpression of MGMT rescued the UBE2B-depleted cells from the cytotoxic concentrations of BCNU, suggesting that MGMT is a downstream target of UBE2B. The E3 ubiquitin ligase RAD18, that is known as a partner of UBE2B in facilitating PCNA ubiquitination, was analyzed to investigate the mechanism of the UBE2B regulation on MGMT. Interaction of RAD18 and MGMT was observed in cancer cells, and was enhanced under the BCNU treatments. Our results also showed that UBE2B and RAD18 contribute to MGMT ubiquitination under in vitro conditions. Conclusions: Our study indicated that the UBE2B-RAD18 regulation on MGMT plays an important role in BCNU-induced cancer cell death. Thus, UBE2B inhibition may be considered as a potential strategy for cancer treatment.
Date:	2017-09
Relation:	Annals of Oncology. 2017 Sep;28(Suppl. 5):Meeting Abstract 55P.
Link to:	https://doi.org/10.1093/annonc/mdx361.050
JIF/Ranking 2023:	http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0923-7534&DestApp=IC2JCR
Cited Times(WOS):	https://www.webofscience.com/wos/woscc/full-record/WOS:000411324000052
Appears in Collections:	[Li-Tzong Chen] Conference Papers/Meeting Abstract [Shang-Hung Chen] Conference Papers/Meeting Abstract

Files in This Item:

File	Description	Size	Format
ISI000411324000052.pdf		44Kb	Adobe PDF	239	View/Open

Loading...